for sale to the public in the respective local market could apply for an expedited review process if it intends to invest in a master fund that meets the requirements set out in the SFC and SEC Circular
outlets (i.e. Rayong and Diana Hat Yai branches) such as depreciation, utilities and marketing expenses related to marketing activities which concentrate to the brand awareness to support sustainable growth
per share are issued and allocated to existing shareholder entitled shares to be set on July 6, 2018 (the Record Date). The newly-issued ordinary shares will be allocated to the existing shareholders at
November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
respective local market could apply for an expedited review process if it intends to invest in a master fund that meets the requirements set out in the SFC and SEC Circular (“MRF-eligible master fund
support the national goal, our strategic plan aims to meet four key objectives of sustainable development, financial inclusion, strengthening competitiveness and building trust and confidence. Amid this
Disposition of Assets"). By acquisition of IGE existing ordinary shares, the Company is required to: 1. Disclosure of Information regarding Class 1 transaction to The Stock Exchange of Thailand (“SET”) under
for Q22018 The management has strongly set its goal to grow sustainably. We would like to present the progress of the following projects; 1. Investment in online live streaming business The Company
issued a legal order to continue the process of execution. Progress Report of Business Plan for Q3 2018 The management has strongly set its goal to grow sustainably. We would like to present the progress